Expert Discusses Impact of Immunotherapy, Molecular Testing Advances in NSCLC – Targeted Oncology
Targeted OncologyExpert Discusses Impact of Immunotherapy, Molecular Testing Advances in NSCLCTargeted OncologyIn a recent interview with Targeted Oncology, Joel Neal, MD, PhD, assistant professor of Medicine (Oncology), Stanford University Medical Cen… Continue reading
